ELV
NYSE · Health Care
Elevance Health Inc
$395.10
+0.28 (+0.07%)
Financial Highlights (FY 2026)
Revenue
192.53B
Net Income
5.47B
Gross Margin
—
Profit Margin
2.8%
Rev Growth
+8.3%
D/E Ratio
0.73
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | — | — | 58.1% | 58.1% |
| Operating Margin | 4.1% | 3.7% | 14.4% | 17.7% |
| Profit Margin | 2.8% | 2.7% | 13.3% | 13.1% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 192.53B | 177.71B | 28.12B | 29.18B |
| Gross Profit | — | — | 16.34B | 16.95B |
| Operating Income | 7.84B | 6.51B | 4.06B | 5.18B |
| Net Income | 5.47B | 4.55B | 3.74B | 3.83B |
| Gross Margin | — | — | 58.1% | 58.1% |
| Operating Margin | 4.1% | 3.7% | 14.4% | 17.7% |
| Profit Margin | 2.8% | 2.7% | 13.3% | 13.1% |
| Rev Growth | +8.3% | +8.3% | +22.0% | +4.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 17.80B | 17.80B | 22.79B | 22.49B |
| Total Equity | 24.38B | 24.38B | 48.97B | 48.10B |
| D/E Ratio | 0.73 | 0.73 | 0.47 | 0.47 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 8.45B | 7.41B | 6.88B | 7.45B |
| Free Cash Flow | — | — | 2.63B | 4.06B |